PriceSensitive

PharmaDrug (CSE:BUZZ) launches online psilocybin retail platform in the Netherlands

Psychedelics
CSE:BUZZ
07 June 2021 09:30 (EDT)

Super Smart, a division of PharmaDrug (BUZZ), has launched its Slim Winkel branded online retail platform in the Netherlands and Europe.

The European Slim Winkel online store will sell psilocybin truffles as well as functional mushrooms in the Netherlands. Other parts of Europe will also have access to the online platform but not to the psilocybin truffles.

The online store was launched to establish the Slim Winkel brand while the company’s brick-and-mortar strategy was put on hold until the end of the COVID-19 pandemic.

The online strategy will benefit Super Smart in four distinct ways:

  1. To establish the Slim Winkel brand and Super Smart’s evolved “Smart Shop” concept;
  2. To continue to curate quality products, which will eventually include its own branded psilocybin truffles in the Netherlands;
  3. To enable Super Smart to continue to develop its psilocybin supply chain; and
  4. To capitalize on an already established distribution model and psilocybin supply chain when other European countries legalize.

“Our concept with Slim Winkel is to create a more modern retail experience in the space; one that blends information and education,” said Super Smart president Harry Resin. “Our goal is to bring psychedelics out of the shadows and make micro dosing a normal part of everyday mental health.”

The current product offering is a curated assortment that will grow as the team sources new products that meet the company’s stringent guidelines.

Visitors to the Dutch Slim Winkel site will be treated to informative blogs and educational tips that will allow them to easily integrate functional mushrooms and psilocybin micro-dosing into their lifestyle.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.

PharmaDrug Inc. (BUZZ) opened trading at $0.08 per share.

Related News